InVivoSIM anti-human CD28 (Theralizumab biosimilar), Clone: [Theralizumab], Human, Monoclonal

Artikelnummer: BXC-SIM0105
Artikelname: InVivoSIM anti-human CD28 (Theralizumab biosimilar), Clone: [Theralizumab], Human, Monoclonal
Artikelnummer: BXC-SIM0105
Hersteller Artikelnummer: SIM0105
Alternativnummer: BXC-SIM0105-100MG, BXC-SIM0105-1MG, BXC-SIM0105-25MG, BXC-SIM0105-50MG, BXC-SIM0105-5MG
Hersteller: Bio X Cell
Wirt: Human
Kategorie: Antikörper
Spezies Reaktivität: Human
Immunogen: Human CD28
Klonalität: Monoclonal
Konzentration: Lot specific,typically between 4-11 mg/ml
Klon-Bezeichnung: [Theralizumab]
Puffer: PBS, pH 7.0, Contains no stabilizers or preservatives
Reinheit: 95% , Determined by SDS-PAGE
Formulierung: Liquid
Target-Kategorie: CD28
Anwendungsbeschreibung: in vivo functional assays, in vitro functional assays, ELISA, Flow cytometry